Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-05-08 4:01 pm Purchase | 13D | FRESH TRACKS THERAPEUTICS INC FRTX | Exploration Capital LLC | 1,273,024 21.300% | 376,024 (+41.92%) | View |
| 2024-01-17 8:37 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Exploration Capital LLC | 897,000 15.000% | 897,000 (New Position) | View |
| 2023-11-27 6:01 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Exploration Capital Fund LP | 597,000 9.990% | 597,000 (New Position) | View |
| 2023-02-13 5:24 pm Sale | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Ionic Ventures LLC | 0 0.000% | -6,094,994 (Position Closed) | View |
| 2022-02-03 3:37 pm Sale | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Ionic Ventures LLC | 6,094,994 5.300% | -1,191,072 (-16.35%) | View |
| 2021-11-03 12:45 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Ionic Ventures LLC | 7,286,066 6.330% | 2,578,016 (+54.76%) | View |
| 2021-07-22 08:59 am Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Ionic Ventures LLC | 4,708,050 5.700% | 4,708,050 (New Position) | View |
| 2021-02-16 09:54 am Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | CVI Investments Inc. | 2,810,675 4.900% | 880,621 (+45.63%) | View |
| 2021-02-11 4:30 pm Sale | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -664,079 (Position Closed) | View |
| 2020-09-24 3:47 pm Purchase | 13D | FRESH TRACKS THERAPEUTICS INC FRTX | Palisade Concentrated Equity Partnership II LP | 1,073,374 3.860% | 60,142 (+5.94%) | View |
| 2020-06-26 4:39 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | ARMISTICE CAPITAL LLC | 1,331,248 4.990% | 1,331,248 (New Position) | View |
| 2020-06-26 10:50 am Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | CVI Investments Inc. | 1,930,054 7.900% | 1,930,054 (New Position) | View |
| 2020-02-27 1:48 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Lincoln Park Capital Fund LLC | 965,723 9.990% | 965,723 (New Position) | View |
| 2020-02-14 4:00 pm Unchanged | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Sio Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2020-02-14 2:56 pm Purchase | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | BIOTECHNOLOGY VALUE FUND L P | 664,079 8.300% | 664,079 (New Position) | View |
| 2020-02-14 10:49 am Unchanged | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | ARMISTICE CAPITAL LLC | 0 0.000% | 0 (Unchanged) | View |
| 2020-02-11 07:02 am Unchanged | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | UBS Group AG UBS | 0 0.000% | 0 (Unchanged) | View |